Metabolic syndrome (MS) is the most common disease today, representing one of the major public health problems of the century and its incidence has gradually increased over time. This metabolic alteration consists of a simultaneous presence of a set of cardiovascular risk factors characterized by hypertension, abdominal obesity, increased triglycerides, decreased high density lipoproteins (HDL- c), and increased glycemia/type 2 diabetes. Flax plant is the most abundant source of omega-3 (αlinolenic acid, ALA). Many studies have shown its positive effects when used as a supplemental feeding. These effects are manifested as improvement in lipid profile, reducing the development of type 1 and type 2 diabetes mellitus, reducing blood pressure and controlling weight gain. In present study two groups each having 50 patients dividing into two groups. Group I patients were given conventional treatment only and will serve as the control group. Group II patients besides conventional treatment were given Alsi/ Flaxseeds and were serve as the study group. Patients included in the study group were asked to take whole flaxseed 3 to 4 table spoons daily. Patients of metabolic syndrome were randomly selected for this study attending the Diabetes Care and Research Center of P.B.M. Hospital, Bikaner within 15 days baseline investigation was completed. This study was conducted in the department of physiology Sardar Patel Medical College, Bikaner. Patients were evaluated weekly for Fasting Blood Sugar level and at baseline and after 3 month for Glycosylated Haemoglobin (Hb1Ac). The results were statistically analysed by applying paired “t” test. The difference was statistically highly significant (p<0.001) for both the parameters. Reduction was more profound in study group than in control group.
